|
2025
|
Invention
|
Inhibitors of human immunodeficiency virus replication. A compound of Formula (I), including phar... |
|
2024
|
Invention
|
Tosylate salt form of a maturation inhibitor for treatment of hiv. The present invention relates ... |
|
|
Invention
|
Methods and intermediates for preparing compounds. The disclosure relates to a process for the pr... |
|
2023
|
Invention
|
Antigen binding proteins. Antigen binding proteins of the invention bind to Human Immunodeficienc... |
|
|
Invention
|
Compounds with hiv maturation inhibitory activity.
The present invention relates to compound of ... |
|
2022
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
A pharmaceutical composition comprising ... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. A pharmaceutical composition comprising t... |
|
2021
|
Invention
|
Inhibitors of human immunodeficiency virus replication. Compounds of Formula I, including pharmac... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. A compound of Formula I, including pharma... |
|
2020
|
Invention
|
Inhibitors of human immunodeficiency virus replication. Compounds and pharmaceutically acceptable... |
|
|
Invention
|
N-substututed-6-oxo-1,6-dihydropyrimidine-2-yl derivatives as inhibitors of the human immunodefic... |
|
|
Invention
|
N-substituted-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl derivatives as inhibitors of the human... |
|
|
Invention
|
Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication. Th... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. The compounds depicted below, and pharmac... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. The compound (I) and pharmaceutically acc... |
|
|
Invention
|
Process for preparing fostemsavir. A method for the preparation of a compound of Formula IV where... |
|
2019
|
Invention
|
Mesylate salt of an amino-lupane compound with hiv maturation inhibitory activity. 322) salt of t... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. Compounds of Formula I, and pharmaceutica... |
|
|
Invention
|
Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus rep... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. Compounds of Formula (I), including pharm... |
|
|
Invention
|
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication. D... |
|
|
Invention
|
Compounds with hiv maturation inhibitory activity. The present invention relates to compound of F... |
|
|
Invention
|
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication.... |
|
2018
|
Invention
|
Antigen binding polypeptides. The invention is directed to an antigen binding polypeptide compris... |
|
|
Invention
|
Crystalline forms of cabotegravir sodium. The present invention relates to crystalline forms of c... |
|
2017
|
Invention
|
Aza-substituted inhibitors of human immunodeficiency virus replication. Compounds having drug and... |
|
|
Invention
|
Azadecalin derivatives as inhibitors of human immunodeficiency virus replication. Compounds havin... |
|
|
Invention
|
Triterpenoid inhibitors of human immunodeficiency virus replication. Compounds having drug and bi... |
|
|
Invention
|
C-3 and c-17 modified triterpenoids as hiv-1 inhibitors. Compounds having drug and bio-affecting ... |
|
|
Invention
|
Fostemsavir for use in heavily treatment-experienced hiv-1 infected individuals. A method of atta... |
|
2016
|
Invention
|
Hiv maturation inhibitor formulations. Co-formulations of HIV maturation inhibitor compound with ... |
|
|
Invention
|
5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3- yl acetic acid derivatives as in... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
Compounds of Formulas I-VI, including ph... |
